Venus Concept (NASDAQ:VERO) Releases Quarterly Earnings Results

Venus Concept (NASDAQ:VERO) issued its earnings results on Monday. The company reported ($11.23) EPS for the quarter, RTT News reports.

Venus Concept Stock Down 24.7 %

NASDAQ:VERO opened at $2.75 on Monday. The company has a debt-to-equity ratio of 2.83, a current ratio of 1.86 and a quick ratio of 1.18. The company’s fifty day moving average price is $3.46 and its 200-day moving average price is $4.22. Venus Concept has a 1-year low of $2.33 and a 1-year high of $17.49. The firm has a market capitalization of $1.82 million, a P/E ratio of -0.34 and a beta of 0.52.

Venus Concept Company Profile

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.